Lv4
540 积分 2024-04-17 加入
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)
1天前
已完结
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)
1天前
已完结
Drug-induced glomerular diseases
8天前
已完结
Luteolin prevents axitinib-induced kidney damage in mice
14天前
已完结
Drug induced nephrotoxicity- A mechanistic approach
26天前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
26天前
已关闭
Associations of acute kidney injury with oral anticoagulants: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
29天前
已完结
Clinical features, sex differences and outcomes of myocardial infarction with nonobstructive coronary arteries: a registry analysis
1个月前
已完结
Evaluation of the post-marketing safety of eculizumab from 2007 to 2025: A real-world pharmacovigilance study and signal analysis based on the FAERS database
1个月前
已完结
Intravenous Interferon-β1a for the Treatment of Ischemia-Reperfusion Injury in Acute Myocardial Infarct in Pigs
4个月前
已完结
皖公网安备34019202002308
